Charmacy Pharmaceutical Co., Ltd. (HKG:2289)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
5.81
0.00 (0.00%)
At close: Mar 27, 2026

Charmacy Pharmaceutical Ratios and Metrics

Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
6277871,0581,400744603
Market Cap Growth
-26.27%-25.61%-24.38%88.10%23.48%2.57%
Enterprise Value
1,1041,5371,6811,6591,5481,675
Last Close Price
5.817.299.1811.855.924.79
PE Ratio
12.1815.2918.6724.757.2821.21
Forward PE
-13.4513.4513.4513.4513.45
PS Ratio
0.130.160.220.290.160.13
PB Ratio
0.911.151.612.131.110.97
P/TBV Ratio
1.041.311.842.471.301.38
P/FCF Ratio
--11.01-18.56-
P/OCF Ratio
--9.38-14.94-
EV/Sales Ratio
0.230.320.360.340.330.36
EV/EBITDA Ratio
6.468.9910.1511.5911.3213.18
EV/EBIT Ratio
7.4510.3811.6913.9114.6518.33
EV/FCF Ratio
--17.50-38.62-
Debt / Equity Ratio
1.921.922.282.301.992.63
Debt / EBITDA Ratio
7.697.698.5410.209.5512.47
Debt / FCF Ratio
--15.61-33.43-
Net Debt / Equity Ratio
0.690.691.351.221.151.36
Net Debt / EBITDA Ratio
2.792.795.375.625.636.62
Net Debt / FCF Ratio
--9.25-5.3119.22-15.37
Asset Turnover
1.181.181.321.441.481.36
Inventory Turnover
5.575.575.756.047.136.51
Quick Ratio
0.620.620.660.630.660.66
Current Ratio
1.091.091.091.071.091.04
Return on Equity (ROE)
7.49%7.49%8.76%8.61%16.46%4.60%
Return on Assets (ROA)
2.24%2.24%2.52%2.21%2.08%1.67%
Return on Invested Capital (ROIC)
9.17%7.67%7.27%6.33%5.62%4.46%
Return on Capital Employed (ROCE)
19.60%19.60%20.20%17.20%15.30%12.30%
Earnings Yield
8.21%6.54%5.36%4.04%13.74%4.72%
FCF Yield
--9.08%-10.81%5.39%-9.08%
Dividend Yield
8.42%-5.22%2.79%8.60%-
Payout Ratio
--120.49%147.05%31.44%226.73%
Buyback Yield / Dilution
0.01%0.01%0.01%-0.00%-0.01%0.01%
Total Shareholder Return
8.42%0.01%5.23%2.79%8.59%0.01%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.